|
|
Volumn 49, Issue 1, 2011, Pages 96-98
|
|
A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatment - A study of the CESAR central european society for anticancer drug research - EWIV
a
|
|
Author keywords
Biomarker; CEUS; Cytostatics; Cytotoxics; DCE MRI; FOLFIRI; Oncology; Pharmacokinetics; Phase II study; Sunitinib
|
|
Indexed keywords
DRUG METABOLITE;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
PHARMACOLOGICAL BIOMARKER;
SU 12662;
SUNITINIB;
UNCLASSIFIED DRUG;
VASCULOTROPIN A;
VASCULOTROPIN RECEPTOR 2;
VASCULOTROPIN RECEPTOR 3;
ANTIANGIOGENIC ACTIVITY;
ANUS FISSURE;
AREA UNDER THE CURVE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SIZE;
CLINICAL ARTICLE;
COLORECTAL CANCER;
CONFERENCE PAPER;
CONTRAST ENHANCEMENT;
CONTROLLED STUDY;
DIAGNOSTIC IMAGING;
DIARRHEA;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG SAFETY;
ECHOGRAPHY;
HAND FOOT SYNDROME;
HUMAN;
INFECTION;
LEUKOPENIA;
LIVER METASTASIS;
LIVER SURGERY;
MONOTHERAPY;
MULTIPLE CYCLE TREATMENT;
NEUTROPENIA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PHASE 2 CLINICAL TRIAL;
PRIMARY HEALTH CARE;
PROTEIN BLOOD LEVEL;
RASH;
RISK BENEFIT ANALYSIS;
STOMATITIS;
THROMBOCYTOPENIA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
COLORECTAL NEOPLASMS;
FLUOROURACIL;
HUMANS;
INDOLES;
LEUCOVORIN;
LIVER NEOPLASMS;
MAGNETIC RESONANCE IMAGING;
PYRROLES;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 78650825835
PISSN: 09461965
EISSN: None
Source Type: Journal
DOI: 10.5414/CPP49096 Document Type: Conference Paper |
|
Times cited : (11)
|
|
References (5)
|
